Hemington Wealth Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$8K Buy
111
+16
+17% +$1.06K ﹤0.01% 965
2025
Q2
$4K Buy
95
+13
+16% +$740 ﹤0.01% 1157
2025
Q1
$5K Buy
82
+27
+49% +$1.57K ﹤0.01% 1046
2024
Q4
$2K Buy
55
+32
+139% +$1.64K ﹤0.01% 1269
2024
Q3
$1K Buy
+23
New +$1.32K ﹤0.01% 1325

Other funds holding HALO

Hemington Wealth Management's HALO Position: Q3 2025 in Review

Hemington Wealth Management increased its Halozyme (HALO) stake by 17% in Q3 2025, buying an estimated $1.06K and bringing the position to 111 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Hemington Wealth Management first reported a position in HALO in Q3 2024 and has held it in 5 quarters since. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

  • Hemington Wealth Management held 111 shares of Halozyme worth $8K as of Q3 2025.
  • Hemington Wealth Management bought 16 Halozyme shares in Q3 2025, an estimated $1.06K.
  • Halozyme made up ﹤0.01% of Hemington Wealth Management's portfolio in Q3 2025, its #965 holding.
  • Hemington Wealth Management first reported a position in Halozyme in Q3 2024 and has held it in 5 quarters since.
  • 602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.